Treatments in the pipeline

Our database lists potential MS treatments that have reported back with promising results from phase II  trials.

It’s important that potential treatments for MS are tested in clinical trials to make sure that the safest and most effective treatments reach people with MS.

Clinical trials are usually completed in three phases before a treatment can be licensed. Around one in 10 potential treatments makes it through all three phases of clinical trials.

Find out more about:

• Alemtuzumab (Campath 1-H, Lemtrada)
• Daclizumab
• Minocycline
• Rituximab
• Stem cell therapy
• Teriflunomide